Modulating levels of RNA-binding proteins for the treatment of breast cancer

The present invention relates to methods of using RNA-binding protein modulating agents to treat of cancer, particularly patients that are susceptible to or diagnosed with estrogen receptor-negative breast cancer, such as methods of inhibiting the growth or metastasis of cancer cells comprising contacting cells with a therapeutically-effective amount of an HuR-modulating agent. The invention also relates to compositions comprising therapeutically-effective amounts of an HuR-modulating agent.

Patents:
US 20,110,110,896

Inventor(s): ATASOY ULUS [US]; GUBIN MATTHEW MICHAEL [US]; CALALUCE ROBERT [US]

Type of Offer: Licensing



« More Biotech Patents

---